Journal
CLINICAL INFECTIOUS DISEASES
Volume 39, Issue 1, Pages 92-97Publisher
OXFORD UNIV PRESS INC
DOI: 10.1086/421558
Keywords
-
Categories
Funding
- NIAID NIH HHS [AI050122] Funding Source: Medline
Ask authors/readers for more resources
Antibiotic-resistant anaerobic bacteria have become increasingly recognized as a confounding factor in the selection of therapeutic agents. The use of potent, broad-spectrum antibiotics as empirical therapy, along with appropriate adjunctive measures, has, in some ways, masked the magnitude of the antibiotic resistance problem that parallels that observed for nonanaerobic pathogens. The use of standardized testing methods that recognize resistance and an understanding of resistance mechanisms have become essential for the treatment of patients and the development of new agents.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available